Teleflex Acquires Essential Medical


October 4, 2018—Teleflex announced that it has acquired Essential Medical, Inc., a privately held company based in Exton, Pennsylvania, that developed and commercialized the Manta vascular closure device.

The Manta device is designed for closure of large-bore arteriotomies after procedures utilizing devices or sheaths ranging in size from 10 to 18 F, with maximum outer diameters up to 25 F.

Teleflex advised that the Manta device is not approved for sale or distribution in the United States. The company anticipates FDA premarket approval of the Manta device in 2019.

Manta has received European CE Mark approval. In the CE Mark study, the Manta device demonstrated rapid and reliable hemostasis with its resorbable collagen-based technology and complication rates that were noninferior to surgical and suture-based closure methods. The study was published in March 2017 by Nicolas M. Van Mieghem, MD, et al in Journal of the American College of Cardiology: Cardiovascular Interventions.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.